Table 4.
Lipid profile in patients with myocardial infarction at 1 and 12 days of the myocardial infarction development
| Variable | Control, n = 33 |
Patients with MI without IR, n = 46 |
Patients with MI and IR, n = 154 |
||
|---|---|---|---|---|---|
| 1-th day | 12-th day | 1-th day | 12-th day | ||
| TC, mmol/liter |
4.30 (3.51;6.10) |
4.71 (3.91;6.45) |
4.35 (3.90;5.00) |
6.00 (5.21;7.01)ac |
5.80 (4.90;7.01)c |
| TG, mmol/liter |
1.13 (0.78;1.23) |
1.15 (0.88;1.35) |
1.83 (1.37;2.28)b |
1.85 (1.31;2.51)ac |
2.14 (1.48;2.97)b |
| HDL-C, mmol/liter |
1.31 (1.02;1.72) |
1.02 (0.82;1.17) |
1.02 (0.83;1.24) |
0.98 (0.74;1.30)a |
0.96 (0.80;1.13)a |
| LDL-C, mmol/liter |
2.03 (1.51;2.55) |
2.13 (1.53;2.57) |
2.45 (1.81;3.90) |
3.10 (2.49;3.63)ac |
3.35 (2.64;4.26)bc |
| VLDL-C, mmol/liter |
0.44 (0.33;0.53) |
0.52 (0.40;0.61) |
0.83 (0.62;1.04)b |
0.84 (0.59;1.14)ac |
0.97 (0.67;1.35)b |
| apo B, g/L |
1.02 (0.76;1.25) |
1.00 (0.78;1.26) |
1.28 (1.05;1.38)b |
1.26 (1.07;1.51)ac |
1.42 (1.04;1.69)b |
| apo A1, g/L |
1.43 (1.29;1.73) |
1.05 (0.93;1.49)a |
1.54 (1.19;1.75)b |
1.27 (1.15;1.43)a |
1.28 (1.14;1.51) |
| apo-В/apo-А1 |
0.71 (0.59;1.01) |
0.90 (0.72;1.16) |
0.81 (0.69;1.09) |
0.97 (0.81;1.25)a |
0.94 (0.77;1.31)c |
| FFA, mcmol/L | 0.20 (0.10;1.10) | 1.20 (0.81;1.86)a | 0.50 (0.43;0.69)b | 1.80 (1.42;213)ac | 0.57 (041;091)b |
Abbreviations: TC, Total cholesterol; TG, Triglycerides; HDL-C, Cholesterol high-density lipoproteins; LDL-C, Cholesterol low-density lipoproteins; VLDL-C, Cholesterol very-low-density lipoproteins; apo B, Apolipoprotein B; apo A1, Apolipoprotein A.
Notes: areliable differences from control (p<0.05).
creliable differences in the indicators on the 1 and 12days (р<0.05);
breliable differences in the parameters between the groups (р<0.05).